קלרידקס

Země: Izrael

Jazyk: hebrejština

Zdroj: Ministry of Health

Aktivní složka:

CLARITHROMYCIN

Dostupné s:

DEXCEL LTD, ISRAEL

ATC kód:

J01FA09

Léková forma:

קפליות

Složení:

CLARITHROMYCIN 250 MG

Podání:

פומי

Druh předpisu:

מרשם נדרש

Výrobce:

DEXCEL LTD, ISRAEL

Terapeutické skupiny:

CLARITHROMYCIN

Terapeutické oblasti:

CLARITHROMYCIN

Terapeutické indikace:

Klaridex is indicated in the treatment of infections caused by one or more susceptible organisms. Indications include: Lower respiratory tract infections, for example, acute and chronic bronchitis and pneumonia. Upper respiratory tract infections, for example, sinusitis and pharyngitis. Klaridex is appropriate for initial therapy in community acquired respiratory infections and has been shown to be active in vitro against common and atypical respiratory pathogens as listed in the microbiology section. Klaridex is also indicated in skin and soft tissue infections of mild to moderate severity. Klaridex is also indicated in combination with proton pump inhibitor for the eradication of H. Pylori in patients with proven duodenal ulcer. Treatment of Mycobacterium Avium Complex infection in AIDS patients.

Datum autorizace:

2014-05-31